🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate whether premedication wit...
Status
Completed
Location
Research Site
Start Date
2012-04
Trial ID
NCT01568112
Treatments Being Tested
The primary objective of the study is to determine the effect of bismuth su...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01915901
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00420212
This study will evaluate the safety, tolerability, and pharmacokinetics of ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-07
Trial ID
NCT02201849
Treatments Being Tested
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00451451
Treatments Being Tested
Purpose of the Clinical Trial: This clinical trial aims to investigate whe...
Status
Recruiting
Location
Deparement of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-01-27
Trial ID
NCT07258394
Treatments Being Tested
The primary objective of the study is to investigate whether treatment with...
Status
Terminated
Location
Research Site
Start Date
2015-05
Trial ID
NCT02430532
Treatments Being Tested
This study was designed to identify whether there is a measurable reduction...
Status
Completed
Location
Beijing Neurosurgical Institute & Beijing Tiantan Hospital
Start Date
2023-07-31
Trial ID
NCT05959759
Treatments Being Tested
The goal of this clinical trial is to assess the degree of improvement in c...
Status
Recruiting
Location
Department of Old Age Psychiatry and Psychotic Disorders Medical University of Lodz
Start Date
2024-10-28
Trial ID
NCT06850597
Treatments Being Tested